Old Web
English
Sign In
Acemap
>
authorDetail
>
Max V. Ranall
Max V. Ranall
University of California, San Francisco
PI3K/AKT/mTOR pathway
Cancer research
Head and neck cancer
Cancer
Receptor tyrosine kinase
4
Papers
55
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Crosstalk signaling between HER3 and HPV16 E6 and E7 mediates resistance to PI3K inhibitors in head and neck cancer
2018
Cancer Research
Toni M. Brand
Stefan Hartmann
Neil E. Bhola
Hua Li
Yan Zang
Rachel A. O'Keefe
Max V. Ranall
Sourav Bandyopadhyay
Margaret Soucheray
Nevan J. Krogan
Carolyn Kemp
Umamaheswar Duvvuri
Theresa M. LaVallee
Daniel E. Johnson
Michelle A. Ozbun
Julie E. Bauman
Jennifer R. Grandis
Show All
Source
Cite
Save
Citations (26)
Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV+ Patients
2017
Clinical Cancer Research
Toni M. Brand
Stefan Hartmann
Neil E. Bhola
Noah D. Peyser
Hua Li
Yan Zeng
Erin Isaacson Wechsler
Max V. Ranall
Sourav Bandyopadhyay
Umamaheswar Duvvuri
Theresa M. LaVallee
Richard Jordan
Daniel E. Johnson
Jennifer R. Grandis
Show All
Source
Cite
Save
Citations (29)
Abstract PR04: HER3 crosstalk with HPV16-E6E7 is a feedback resistance mechanism to PI3K-targeted therapies in head and neck cancer
2017
Clinical Cancer Research
Toni M. Brand
Stefan Hartmann
Neil E. Bhola
Hua Li
Yan Zeng
Rachel A. O'Keefe
Max V. Ranall
Sourav Bandyopadhyay
Margaret Soucheray
Danielle L. Swaney
Nevan J. Krogan
Carolyn Kemp
Umamaheswar Duvvuri
Daniel E. Johnson
Michelle A. Ozbun
Julie E. Bauman
Jennifer R. Grandis
Show All
Source
Cite
Save
Citations (0)
Connecting tumor genomics with therapeutics through multi-dimensional network modules
2016
bioRxiv
James T. Webber
Max V. Ranall
Swati Kaushik
Sourav Bandyopadhyay
Show All
Source
Cite
Save
Citations (0)
1